21-DEC-2024 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support		 STUDY R
E
G		 O
P
E
N		 ARM ACCR.
GOAL		 TOTAL
REGS.		 REGS.
LAST
12
Month		 REGS.
LAST
6
Month		 REGS.
LAST
3
Month		 REGS.
LAST
30
DAYS		 REGS.
LAST
7
DAYS		 DATE OF
FIRST
REG.		 # of
ACT.
INSTs		 # of
CURR
IRBs
SWOG S2012-Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 Y 1 Platinum/Etoposide + Atezo Induction + Maintenance 189 27 16 9 6 4 2 06/28/2022 224 74
        2 Platinum/Etoposide + Atezo Induction   23 12 7 4 2 0      
        3 Platinum/Etoposide Only   22 12 8 4 2 0      
            72 40 24 14 8 2      
 
  EAY191-S3-ComboMATCH: Adv Solid Tumors, Pac+Ipatasertib 1 Y 1 Paclitaxel + Ipatasertib 33 8 7 6 4 2 1 09/22/2023 171 66
            8 7 6 4 2 1      
 
Yes A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   49 6 2 1 1 1 02/22/2016 257 85
            49 6 2 1 1 1      
 
    1 E Total Registrations   8 0 0 0 0 0 02/22/2016    
            8 0 0 0 0 0      
 
  EAY191A3-ComboMATCH-RAS-Mutant, All Stg, Palbo+Benim 1 E Total Registrations   2 2 0 0 0 0 02/08/2024 206 79
            2 2 0 0 0 0      
 
No AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 1 E Total Registrations   2 0 0 0 0 0 10/07/2021 186 114
            2 0 0 0 0 0      
 
  EAY191-ComboMATCH 1 E Total Registrations   11 8 2 1 1 0 08/03/2023 274 116
            11 8 2 1 1 0      
 
  EAY191A6-ComboMATCH: MAPK Tumors, Adv Stg, FOLFOX+Bin 1 E Total Registrations   1 1 1 0 0 0 07/18/2024 187 73
            1 1 1 0 0 0      
 

21-DEC-2024 6:10

ERLYTX Open Studies with No Registrations

Study Registration/Phase Open Date # of
ACT.
INSTs		 # of
CURR
IRBs
AGCT1531 Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 2 Late Randomization Callback 08-May-17 186 114
EAY191 ComboMATCH 2 Re-Screening 06-Mar-23 274 116
EAY191A3 ComboMATCH-RAS-Mutant, All Stg, Palbo+Benim 2 Cohort Migration 15-Nov-23 206 79